SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
9193365
Source:
http://linkedlifedata.com/resource/pubmed/id/9193365
Search
Subject
(
65
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0030705
,
umls-concept:C0040113
,
umls-concept:C0079731
,
umls-concept:C0085415
,
umls-concept:C0205225
,
umls-concept:C1096776
,
umls-concept:C1514474
,
umls-concept:C1522718
pubmed:issue
4
pubmed:dateCreated
1997-7-10
pubmed:abstractText
To define clinicopathologic features, response to treatment, and prognostic factors of primary mediastinal B-cell lymphoma (MBL), a CD20+ tumor recognized as a distinct entity among non-Hodgkin's lymphomas (NHL).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0732-183X
pubmed:author
pubmed-author:BernasconiCC
,
pubmed-author:GambacortaMM
,
pubmed-author:GargantiniLL
,
pubmed-author:GianellaMM
,
pubmed-author:KlersyCC
,
pubmed-author:Lavabre-BertrandTT
,
pubmed-author:LazzarinoMM
,
pubmed-author:MöllerPP
,
pubmed-author:MagriniUU
,
pubmed-author:ManegoldCC
,
pubmed-author:MarraEE
,
pubmed-author:OrlandiEE
,
pubmed-author:PaulliMM
,
pubmed-author:RoussetM TMT
,
pubmed-author:SträterJJ
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1646-53
pubmed:dateRevised
2006-4-24
pubmed:meshHeading
pubmed-meshheading:9193365-Adolescent
,
pubmed-meshheading:9193365-Adult
,
pubmed-meshheading:9193365-Aged
,
pubmed-meshheading:9193365-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:9193365-Disease-Free Survival
,
pubmed-meshheading:9193365-Doxorubicin
,
pubmed-meshheading:9193365-Europe
,
pubmed-meshheading:9193365-Female
,
pubmed-meshheading:9193365-Humans
,
pubmed-meshheading:9193365-Lymphoma, B-Cell
,
pubmed-meshheading:9193365-Male
,
pubmed-meshheading:9193365-Middle Aged
,
pubmed-meshheading:9193365-Neoplasm Staging
,
pubmed-meshheading:9193365-Prognosis
,
pubmed-meshheading:9193365-Radiotherapy, Adjuvant
,
pubmed-meshheading:9193365-Retrospective Studies
,
pubmed-meshheading:9193365-Risk Factors
,
pubmed-meshheading:9193365-Survival Analysis
,
pubmed-meshheading:9193365-Thymus Neoplasms
,
pubmed-meshheading:9193365-Treatment Outcome
pubmed:year
1997
pubmed:articleTitle
Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients.
pubmed:affiliation
Department of Pathology, University of Pavia, Italy.
pubmed:publicationType
Journal Article
,
Multicenter Study